Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7814147

CSc1ccsc1C(=N)N.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 5/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ PTPRG P23470 5/20 0.37
▸ BCAT2 O15382 1/20 0.33
▸ AR P10275 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PLAU P00749 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ KLK1 P06870 1/20 0.32
▸ KLK5 Q9Y337 1/20 0.32
▸ F2 P00734 2/20 0.32
▸ F11 P03951 2/20 0.32
▸ PRSS1 P07477 2/20 0.32
▸ PRSS2 P07478 2/20 0.32
▸ PRSS3 P35030 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5841746 0.86 PLAU (0.41) PTPRCKMT2APTPRGBCAT2AR
Hydrochloric Acid SCHEMBL7357455 0.84 PLAU (0.40) PTPRCKMT2APTPRGBCAT2AR
SCHEMBL7246054 0.77 KMT2A (0.56) PTPRCKMT2APTPRGLMNAMAPT
Trifluoroacetic Acid SCHEMBL27554832 0.70 DPP4 (0.37) KMT2ABCAT2MAPTF2
Trifluoroacetic Acid SCHEMBL5658568 0.70 GSK3B (0.46) KMT2ABCAT2MAPTGAAHPGD
Trifluoroacetic Acid SCHEMBL5223272 0.70 PLAU (0.72) PLAUKLK1KLK5F2
SCHEMBL7886053 0.69 KMT2A (0.39) PTPRCKMT2APTPRGARLMNA
Trifluoroacetic Acid SCHEMBL5223817 0.67 DAO (0.50) KMT2ALMNAALDH1A1GAAHPGD
SCHEMBL20504888 0.65 ALDH1A1 (0.34) KMT2ABCAT2MAPTKDM4EALDH1A1
Benzamidine SCHEMBL5241617 0.63 F2 (0.67) KMT2AMAPTKLK1KLK5F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1152759-A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-11-14 — — EP disclosed
WO-2000047194-A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR DIMENSIONAL PHARM INC (US) 2001-05-31 — — WO disclosed
WO-2000047194-A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 — — WO disclosed
Send feedback